These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 21705198)

  • 1. Spread of imipenem-resistant Acinetobacter baumannii of European clone II in Western China.
    He C; Xie Y; Fan H; Kang M; Tao C; Zhang R; Hu Y; Chen Z; Wang L
    Int J Antimicrob Agents; 2011 Sep; 38(3):257-60. PubMed ID: 21705198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China.
    Fu Y; Zhou J; Zhou H; Yang Q; Wei Z; Yu Y; Li L
    J Antimicrob Chemother; 2010 Apr; 65(4):644-50. PubMed ID: 20154023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran.
    Peymani A; Higgins PG; Nahaei MR; Farajnia S; Seifert H
    Int J Antimicrob Agents; 2012 Jun; 39(6):526-8. PubMed ID: 22521767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.
    Tsakris A; Ikonomidis A; Poulou A; Spanakis N; Vrizas D; Diomidous M; Pournaras S; Markou F
    Clin Microbiol Infect; 2008 Jun; 14(6):588-94. PubMed ID: 18397334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase.
    Lu PL; Doumith M; Livermore DM; Chen TP; Woodford N
    J Antimicrob Chemother; 2009 Apr; 63(4):641-7. PubMed ID: 19182237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
    Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
    Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
    Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
    J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain.
    Ruiz M; Marti S; Fernandez-Cuenca F; Pascual A; Vila J
    Clin Microbiol Infect; 2007 Dec; 13(12):1192-8. PubMed ID: 17850347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy.
    Mezzatesta ML; D'Andrea MM; Migliavacca R; Giani T; Gona F; Nucleo E; Fugazza G; Pagani L; Rossolini GM; Stefani S
    Clin Microbiol Infect; 2012 Feb; 18(2):160-6. PubMed ID: 21722261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility.
    Zander E; Chmielarczyk A; Heczko P; Seifert H; Higgins PG
    J Antimicrob Chemother; 2013 Feb; 68(2):308-11. PubMed ID: 23014718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
    Wang H; Guo P; Sun H; Wang H; Yang Q; Chen M; Xu Y; Zhu Y
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4022-8. PubMed ID: 17846127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different international clonal lineages.
    Karah N; Giske CG; Sundsfjord A; Samuelsen Ø
    Microb Drug Resist; 2011 Dec; 17(4):545-9. PubMed ID: 21830948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan.
    Lee YT; Huang LY; Chiang DH; Chen CP; Chen TL; Wang FD; Fung CP; Siu LK; Cho WL
    Int J Antimicrob Agents; 2009 Dec; 34(6):580-4. PubMed ID: 19733035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.
    Ben RJ; Yang MC; Hsueh JC; Shiang JC; Chien ST
    Int J Antimicrob Agents; 2011 Nov; 38(5):403-8. PubMed ID: 21871784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a teaching hospital in China.
    Hu Q; Hu Z; Li J; Tian B; Xu H; Li J
    J Basic Microbiol; 2011 Oct; 51(5):467-72. PubMed ID: 21656808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals.
    Park YK; Choi JY; Jung SI; Park KH; Lee H; Jung DS; Heo ST; Kim SW; Chang HH; Cheong HS; Chung DR; Peck KR; Song JH; Ko KS
    Diagn Microbiol Infect Dis; 2009 Aug; 64(4):389-95. PubMed ID: 19631092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182.
    Kim CK; Lee Y; Lee H; Woo GJ; Song W; Kim MN; Lee WG; Jeong SH; Lee K; Chong Y
    Diagn Microbiol Infect Dis; 2010 Dec; 68(4):432-8. PubMed ID: 20884158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China.
    Ruan Z; Chen Y; Jiang Y; Zhou H; Zhou Z; Fu Y; Wang H; Wang Y; Yu Y
    Int J Antimicrob Agents; 2013 Oct; 42(4):322-8. PubMed ID: 23988720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.